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Abstract: Background: Peri-implantitis is an inflammatory disease with an increasing diffusion rate 
which can affect the long-term survival of a prosthetic rehabilitation. The present study focused on 
the decontaminating efficacy of chlorhexidine and air polishing system with sodium bicarbonate 
powder against Candida albicans, a microorganism which seems to have a superinfecting 
opportunistic role in the pathology. The aim of the authors was to investigate and compare the 
effectiveness of these treatments, commonly used in clinical practice. Methods: An in vitro study 
was conducted to analyze the effects of two widely used therapeutic aids for the disinfection of 
affected titanium implants: chlorhexidine (CHX) and air polishing with sodium bicarbonate powder 
(P). A qualitative and quantitative comparative analysis of the residual biofilm was carried out using 
a colorimetric assay (XTT) and scanning electron microscopy (SEM) observation. The experiment 
was conducted both on machined titanium surfaces and on rough sandblasted ones with the aim of 
bringing out differences in the therapeutic outcomes concerning the superficial texture of the 
implant. The null hypothesis was that no difference could be detected between the samples, 
regarding both the treatments performed and the nano-structural features of titanium. Results: The 
best results (on both types of implant surfaces) were obtained when combining the use of 
chlorhexidine and air polishing (C + P). A linear decrease in the optical density (OD) values recorded 
at three different time points (30 s, 1 min, 5 min) was also observed passing from the first to the last 
one. When observed under scanning electron microscope rough surfaces showed an extensive and 
highly structured biofilm, more complex if compared to the one encountered when analyzing 
machined implants. Conclusions: the present pilot study showed that rough surfaces can promote 
fungal adhesion and eventually hinder the outcome of a decontaminating treatment. For this 
purpose, the physio-chemical technique is always more efficient if compared to a single-technique 
approach regardless of the surface characteristics. 
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1. Introduction 
In modern dentistry, the use of titanium implants to restore edentulous areas of various 
extension is a very common practice [1–3], followed by a great percentage of long-term success [4]. 
Systemic or syndromic diseases [5,6] and immune disorders [7] should be evaluated before the 
implant placement in order to avoid post-operative bleeding-related complications [8,9] and to 
achieve better outcomes. An accurate exam of the bone crest, in terms of width and height, is also 
important for proper planning of the implant [10–14].  
Once a dental implant is placed into the oral cavity its surface gets exposed to the oral 
environment, a very complex one characterized by a huge variety of resident microorganisms. The 
biodiversity of the oral microflora (over 600 different microbial species can be counted) and its 
balance with the host’s immune system is one of the defining factors of both health and well-being of 
peri-implant tissues [15].  
Peri-implantitis is an inflammatory disease with bacterial etiology which affects the periodontal 
tissues surrounding a dental implant, accompanied by the progressive loss of supporting bone [16]. 
If not actively treated this pathology can lead to implant failure because of loss of osseointegration 
due to bone resorption [17].  
Different studies have demonstrated that the subgingival microflora located in a periodontal 
pocket surrounding a titanium implant is far more complex compared to the one rediscovered in 
periodontitis [18] and that teeth and implants seem not to share the same microbiome, even in healthy 
conditions [19]. In fact, titanium can be easily colonized also by opportunistic pathogens which are 
not usually part of the oral microflora such as Staphylococcus aureus, Pseudomonas aeruginosa, 
Enterobacteriaceae and Candida albicans [20,21].  
A small number of authors have focused their attention on the effective role of these 
superinfecting pathogens within the peri-implant disease. It is believed that they can sustain and 
worsen post-surgical oral infections when present in subgingival pockets together with the putative 
periodontopathogenic bacteria. They are usually associated with aggressive and recalcitrant forms of 
peri-implantitis, resistant to the therapeutic agents commonly used, besides being potential sources 
of systemic infections, especially dangerous for immunocompromised patients [22]. Even though 
their etiopathogenetic role needs to be further investigated, their virulence factors could suggest a 
possible involvement in the pathogenesis of peri-implantitis, especially with regards to Candida 
albicans [23].  
This fungus can play a role in the development and progression of the disease because of its 
capacity of colonizing epithelial surfaces, inhibiting the function of polymorphonuclear neutrophil 
and secretion of lytic enzymes like collagenases, phospholipase, and proteinases. They can facilitate 
the penetration into the epithelial cell, the invasion of the gingival connective tissue, and the 
degradation of the immunoglobulins [24]. Furthermore, Candida albicans can induce inflammatory 
reactions and co-aggregate to different microorganisms, especially various species of streptococci and 
Fusobacterium nucleatum, contributing to the formation of multispecies biofilms [25]. They bind 
together throughout recognition receptor polysaccharides on the bacterial surface [26]. The 
simultaneous presence of microorganisms involved in the pathogenesis of peri-implantitis seems to 
upregulate its hyphal production and the expression of hydrolytic enzymes and genes associated 
with adhesion (ALS1 and ALS3) [27]. Candida albicans was found in the outer layer of subgingival 
biofilms associated to cases with poor response to the conventional treatment. Here it seemed to have 
a protective role in favor of the microorganisms of the deep interior from the action of immune 
mechanisms, thus aiding the resistance of the subgingival microbiota and contributing to the 
persistence of inflammation [28].  
The treatment of peri-implantitis consists of the mechanical debridement of the infected metallic 
fixture to eradicate the pathological biofilm. The irregular rough surface of fixtures, highly micro and 
macro-structured to improve osseointegration, facilitates initial microbial adhesion and the 
formation of biofilms and makes sufficient debridement of implant surface very difficult to achieve 
[29,30]. Clinicians follow a combined protocol with the use of a variety of antimicrobial agents as 
adjunctive instruments helping to enhance and sustain the outcomes of surgical therapy [15–17]. Both 
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mechanical (implantoplasty, air powder abrasive systems, laser and photodynamic therapy) and 
chemical agents (chlorhexidine, citric acid, hydrogen peroxide, antimicrobials) have been evaluated 
but still there is no evidence about what agent or technique should be used in the clinical practice for 
its superior efficacy [31–33]. 
The aim of the present study is to evaluate and compare the decontaminating properties of two 
of the most commonly used therapeutic agents in the treatment of peri-implantitis against Candida 
albicans: chlorhexidine (CHX) and air polishing with sodium bicarbonate powder used alone and then 
combined. The evaluation was conducted both on smooth and rough (sandblasted and acid etched) 
implants to highlight eventual differences in the outcomes related to the type of surface. 
2. Results 
Regarding machined implants, the sample used as a control showed the most intense coloration 
in the colorimetric assay (XTT) assay whereas the other experimental groups showed a color of 
decreasing intensity throughout the different time points: from a light orange observed at 30 s to no 
color recorded after 5 min (see optical density (OD) values in Table 1).  
Table 1. Optical density (OD) values of all samples. 
Machined Implants 
Treatment Timing Optical Density  Mean  SD p-Value 
CHX 30 s 0.407 0.419 0.045 0.419 0.045 0.0094* 
CHX 1 min 0.088 0.171 0.051 0.171 0.051 0.0013* 
CHX 5 min 0.124 0.113 0.041 0.113 0.041 0.0007* 
C + P 30 s 0.103 0.126 0.016 0.126 0.016 0.0006* 
C + P 1 min 0.043 0.052 0.011 0.051 0.011 0.0003* 
C + P 5 min 0.017 0.024 0.014 0.023 0.014 0.0003* 
Control - 0.826 0.738 0.084 0.738 0.084 0.999 
Rough Implants 
CHX 30 s 0.543 0.471 0.573 0.529 0.043 0.001* 
CHX 1 min 0.205 0.17 0.144 0.163 0.037 0.0002* 
CHX 5 min 0.188 0.158 0.142 0.162 0.019 0.0002* 
C + P 30 s 0.045 0.041 0.043 0.042 0.001 0.0001* 
C + P 1 min 0.035 0.014 0.018 0.043 0.012 0.0001* 
C + P 5 min 0.035 0.059 0.033 0.022 0.009 0.0001* 
Control - 1.563 1.356 1.239 1.386 0.133 1 
BLK - - 0 −0.001 0.002 - - - 
Differences in the color intensity were also recorded between the types of treatment. Although both 
treatments determined a significant reduction in terms of OD at 5 min compared to the control sample 
(p-value CHX at 5 min = 0.0007; p-value C + P at 5 min = 0.0001), the use of air polishing (C + P) gave 
more promising results rather than chlorhexidine (CHX) used alone for all samples exposed to it (p-
value CHX vs. C + P = 0.0173). The most striking difference between the treatments can be observed 
at the first time point (30 s): the use of air polishing allows obtaining a 4–5 points reduction in the OD 
values recorded with the use of CHX alone, both on machined and rough implants. Abbreviations: 
CHX = chlorhexidine; C + P = chlorhexidine + air polishing; BLK = blank, 0 value 
For a visual analysis of the results obtained on machined implants see Figure 1: the comparative 
histogram in the picture shows the mean efficacy of both treatments at each time point if compared 
to the control group and also reveals the reduction of the OD values recorded with the increasing of 
the time spent undergoing both types of treatment. In the end, considering the differences between 
the two therapeutic strategies, the combined one appeared to always be more effective rather than 
the simple use of CHX.  
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Figure 1. Efficacy of treatments on machined samples. Abbreviations: C = chlorhexidine; C + P = 
chlorhexidine + air polishing. 
The same affirmation can be made with regards to rough implants. In fact, the histogram of 
Figure 2 shows the same decrease of the OD values related with the increase of time spent 
decontaminating the surfaces and the better efficacy of the double approach at each time point. 
The most significant p-values were recorded at 5 min with the combined treatment (p = 0.0001 
vs. p = 0.0002 obtained with CHX alone).  
 
Figure 2. Efficacy of treatments on rough samples. Abbreviations: C = chlorhexidine; C + P = 
chlorhexidine + air polishing. 
In conclusion, it is possible to state that the best decontamination on both types of surfaces was 
obtained combining the use of air polishing and chlorhexidine. In fact, all p-values obtained from the 
comparison were significant (see Tables 2 and 3). 
Table 2. Comparative table for smooth surfaces. 
Surface Timing  Treatment Mean  p-Value 
Machined 30 s  CHX 0.419 
0.001 
Machined 30 s C + P 0.126 
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Machined 1 min CHX 0.114 
0.1054 
Machined 1 min C + P 0.052 
Machined 5 min CHX 0.172 
0.0173 
Machined 5 min C + P 0.024 
Table 3. Comparative table for rough surfaces. 
Surface Timing Treatment Mean  p-Value 
Rough  30 s  CHX 0.529 
<0.0001 
Rough 30 s C + P 0.043 
Rough 1 min CHX 0.163 
0.0067 
Rough 1 min C + P 0.022 
Rough 5 min CHX 0.163 
0.0016 
Rough 5 min C + P 0.042 
The above-mentioned outcomes were confirmed during the observation of the samples with the 
use of a scanning electron microscope (SEM). From Figures 3–6 it is easy to have an immediate 
visualization of the major effectiveness of the combined treatment protocol on both types of surfaces 
if compared to the use of CHX alone: in fact Figures 3 and 5 show the presence of a residual well-
structured biofilm which was not disrupted, whereas Figures 4 and 6 show completely 
decontaminated fixtures. Comparing these images, it is also possible to visualize how surface 
roughness promotes the adhesion and the formation of a complex and more extended biofilm giving 
microorganisms a better adhesive substratum rather than a smooth one, which happened to be even 
more easily treatable. As far as surface characteristics are concerned, it is evident how this element 
plays a major role both in the contamination and the decontamination phase (see Tables 2 and 3), 
confirmed by the OD values recorded in the control groups: the ones registered on the rough control 
are doubled when compared to the machined control ones whereas the OD values recorded after the 
C + P treatment on the sandblasted implants were higher than the ones recorded on the machined 
samples.  
 
Figure 3. Chlorhexidine (CHX) treatment on a machined implant. Magnification 158×. 
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Figure 4. Air polishing and CHX treatment on a machined implant. Magnification 239×. 
 
Figure 5. CHX treatment on a sandblasted implant. Magnification 95×. 
 
Figure 6. Air polishing and CHX treatment on a sandblasted implant. Magnification 138×. 
3. Discussion 
The present study focused on the efficacy of two treatment commonly used for the eradication 
of microbial biofilms from machined and rough titanium infected fixtures affected by peri-implantitis 
[34–36].  
Candida albicans single-species biofilms were chosen because of their opportunistic role in the 
development of peri-implant disease and participation in the composition of sub-gingival peri-
implant microflora [22–24]. Although frequently isolated as part of the peri-implant microflora, the 
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etiopathogenetic role of Candida albicans within peri-implantitis is still unknown and needs further 
investigations but the microorganism’s virulence factors suggest its possible involvement in the 
pathogenetic process of the disease as they could sustain the progression of peri-implantitis [23].  
Through this study, it was possible to demonstrate Candida albicans’ affinity for biomaterials, 
especially for titanium [37,38]. The persistence of pathogenic microorganisms adhering to implant 
surfaces is a clinically relevant problem, not just for the health of surrounding tissue and the implant, 
but also for the health of immunocompromised hosts. 
The same attention to the control of active infection is needed when treating patients affected 
also by cardiovascular diseases (CVD): it has been demonstrated how high serum levels of c-reactive 
protein (CRP) are major predictors for high serum and salivary levels of endothelin 1 (ET-1). ET-1 
plays a key role in the maintenance of homeostasis of endothelium thus having a possible correlation 
with the onset of CV events [39]. 
In these patients, microorganisms organized in a biofilm, which are more resistant to host 
defenses and conventional antimicrobial therapies, could spread through the ulcerate epithelium of 
the peri-implant pocket and become a source of persistent infections [37,38,40]. That is why dental 
implants covered by a pathogenic biofilm may be a source of recalcitrant infection and potential 
reservoirs of reinfection.  
Both treatments (CHX and C + P) were active against the fungus, confirming the findings of 
previous studies on their clinical utility [40–44] but comparing the OD values for the two treatments 
and p-values obtained from the statistical analysis it is evident how the air polishing system has the 
most relevant decontaminating power if compared to the use of CHX alone [45,46]. It mechanically 
disrupts the biofilm and so CHX does not seem to add any microbiological benefit to it, although 
always maintaining its clinical efficacy thanks to its antimicrobial properties [47].  
Their combination resulted in a better strategy for the management of pathogenic biofilms with 
the possibility of overcoming the limitations of the chemical treatment alone, especially in the case of 
irregular surfaces, here empowering the outcome of a decontaminating treatment. 
In the specific case of Candida albicans, the small irregularities of the sandblasted surface furnish 
the microorganism with protective niches from shear forces due to their dimensions (which are 
similar to the ones of the microorganism) and favor the biofilm formation [38].  
4. Materials and Methods  
We tested 14 titanium implants measuring 5.2 mm in diameter and 10 mm long: seven implants 
presented a smooth machined surface whereas the other seven implants were rough sandblasted and 
acid etched. All implants were NQ implants and belonged to the UniQo line provided by Falappa 
Medical Devices (FMD, Rome, Italy). 
4.1. In Vitro Biofilm Formation 
Candida albicans clinical strain HBF6001 (taken from the internal storage of the Institute of 
Microbiology and Virology, Foundation Agostino Gemelli University Policlinic) was inoculated in 5 
mL RPMI 1640 (ThermoFischer Scientific, Waltham, Massachusetts, USA) and incubated at 37 °C for 
24 h on a shaking incubator (Iris Analytical Ltd, Camberley, England) at 150 r.p.m. (rotations per 
minute) (after 24 h cells usually reach a concentration of 1 × 108 cells per mL). Then a 1:100 dilution of 
the original inoculum was made as follows: 13.5 mL RPMI 1640, 1.5 mL FCS (Fetal Calf Serum Sigma-
Aldrich, St Louis, Missouri, USA), 150 μL inoculum, 15 μL gentamicin (Sigma-Aldrich, St Louis, 
Missouri, USA), and 15 μL vancomycin (Sigma-Aldrich, St Louis, Missouri, USA). Antibiotics were 
used to avoid bacterial growth in the solution and fetal calf serum to induce the expression of genes 
coding for virulence factors.  
The solution was kept in incubator on a shaking plate at 37 °C for 2 h and 30 min until an optical 
density of 0.7 read at 600 nm wavelength was reached, in order to have an approximative 
concentration of 1 × 107 cells per mL. The solution was centrifuged at 4000 r.p.m. for 5 min and, after 
having discarded the supernatant, the cell pellet was resuspended in 15 mL of the same culture 
medium as before (13.5 mL RPMI 1640, 1.5 mL FCS, 15 μL gentamycin, and 15 μL vancomycin). The 
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14 implants were immersed into the solution and kept in a shaking incubator at 30 °C for 48 h. The 
culture medium was refreshed after 48 h after rinsing each implant with PBS (phosphate buffered 
saline Sigma-Aldrich, St Louis, Missouri, USA), to remove the cells loosely adherent to the implant 
surface but not really organized in a biofilm. After that, all the implants were placed again in a 
shaking incubator at 30 °C. The culture medium was refreshed after 48 h for a total incubation period 
of 1 week to guarantee the fungus the ideal condition for the gene expression of its virulence factors 
implied in the adhesion phase to the substratum.  
4.2. Implant Surface Decontamination 
All implants were rinsed with sterile water for injections. One machined and one rough implant 
were used as a control, so they did not undergo any decontamination. They were kept first in saline 
(NaCl 0.9%) and then placed in formaldehyde 2%. The 12 remaining implants were located into six 
experimental groups, each composed of two specimens:  
 Group 1: one machined and one rough implant treated with chlorhexidine 0.2% (Curasept 
ADS 0.2%, Curaden HealthCare Spa, Saronno, Italy) for 30 s. 
 Group 2: one machined and one rough implant first treated with air polishing with sodium 
bicarbonate powder and then immersed in chlorhexidine 0.2% for 30 s. 
 Group 3: one machined and one rough implant treated with chlorhexidine 0.2% for 1 min.  
 Group 4: one machined and one rough implant first treated with air polishing with sodium 
bicarbonate powder and then immersed in chlorhexidine 0.2% for 1 min.  
 Group 5: one machined and one rough implant treated with chlorhexidine 0.2% for 5 min.  
 Group 6: one machined and one rough implant first treated with air polishing with sodium 
bicarbonate powder and then immersed in chlorhexidine 0.2% for 5 min.  
All implants were treated by the same operator with Prophyflex III® 2018 (KaVo, Biberach, 
Germany), under a pressure range between 3.2 and 5 bar. The nozzle was always kept at a distance 
of 3–5 mm from the implant surface with an angulation of 60–90° with the long axis of the implant. 
Each implant was instrumented for 1 min using regular movements of the nozzle along the surface 
of the fixture trying not to stop for more than 10 s on the same spot.  
4.3. Quantification of Biofilms 
Biofilms on each implant surface were quantified using XTT (ThermoFischer Scientific, 
Waltham, Massachusetts, USA) assay, performed after drying all the samples with sterile gauzes. 
First, 10 mL of XTT was activated adding 10 μL of menadione and the total volume was divided for 
the 14 samples. XTT (2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-
tetrazolium hydroxide) is a colorimetric assay used for the quantification of the vitality of the fungal 
cells of a biofilm. The assay is based on the transformation of XTT, a colorless tetrazolium salt, into 
water-soluble formazan, which has an orange dye ranging from light to bright. The assay shows a 
direct correlation between the number of viable cells and the intensity of the color obtained: the 
higher the intensity of the color, the higher the quantity of ATP contained in the solution, and so the 
number of viable cells adherent to the surface with metabolic activity, being dehydrogenases and 
reductases mitochondrial enzymes responsible for the chemical reaction. Each test should include a 
blank containing complete medium without cells used as a background control in order to have a 
comparison among the OD values recorded from the samples with the spectrophotometer. The 
samples were kept in the dark in a CO2 incubator at 37° and the results observed after 2 h. Finally, 
300 μL of the solution where each sample was immersed was used for the recording of their OD by 
means of a spectrophotometer (Artiglass srl, Padova, Italy) 
The optical density of each sample was read in triplicate, dividing 300 μL in three wells 
containing 100 μL each, and at a wavelength of 490 nm using the OD of the inactivated XTT as the 0 
value (BLK). After recording the values samples were kept in formaldehyde 2% for 24 h to avoid the 
degradation of the organic parts of the biofilm. XTT analysis and SEM observation were used in 
association to evaluate the extension and the morphology of biofilms [48,49]. XTT has a high 
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sensitivity for the quantification of cells’ viability and the data recorded were then confirmed by the 
images observed with the SEM analysis (see Figures 3–6).  
4.4. SEM Observation 
All samples were then rinsed with sterile water for injections and progressively dehydrated by 
immersion in 70% alcohol and 90% pure alcohol for 45 min each. Once dried all implants were 
mounted onto metallic stubs and metalized by electrodeposition of Au/Pa 60/40. The entire surface 
of each sample was observed, and images were taken at 50× and 100× magnification. Then, additional 
magnification of 1000× and 2000× was used to discover the details of biofilms particularly structured 
and largely extended on the metallic surface. This entire observational phase was conducted using a 
scanning electron microscope (SEM Supra 25, Carl Zeiss, Germany) held by the Department of 
Physics of the Catholic University of the Sacred Heart.  
4.5. Statistical Analysis 
Statistical analysis was undertaken by an independent statistician with IBM SPSS Statistics 
software v.25 (IBM; Chicago, IL, USA). p-values were calculated for each group through parametric 
Student’s t-test and results with p < 0.05 were recorded as significant.  
5. Conclusions 
The present in vitro study showed the affinity of Candida albicans for titanium and the differences 
in terms of colonization between smooth and rough surfaces.  
Dental implants can become a good substratum for fungal biofilm formation. Yeast cells have a 
high potential to adhere to artificial materials and the properties of the surface (i.e., roughness) 
influence the quantity and quality of fungal adhesion. Roughness provides a better osseointegration 
but enhances bacterial and fungal colonization and represents a very difficult device to 
decontaminate. 
The results obtained from this study confirm the effectiveness of the airflow as a decontaminant 
instrument in the case of an infected fixture if compared to the use of CHX alone and the superiority 
of the combined treatment. This finding might be useful for a more efficient therapeutic approach 
against well-structured biofilms which are notoriously more resistant to conventional antimicrobial 
agents, not only with the aim of preserving the functionality of the rehabilitation but also for 
protecting and keeping the systemic health status of our patients.  
The present study should be considered as a pilot study and its results might be used as a basis 
for further investigations conducted on multi-species biofilms.  
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